4.6 Article

Recent advances in hidradenitis suppurativa: Role of race, genetics, and immunology

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Variant Enrichment Analysis to Explore Pathways Functionality in Complex Autoinflammatory Skin Disorders through Whole Exome Sequencing Analysis

Lucas Andre Cavalcanti Brandao et al.

Summary: Unravelling the molecular basis of multifactorial disorders requires new genomic analysis tools that focus on disrupted pathways rather than associated gene variants, as association studies have limitations in understanding the interactions between disease-causing variants. In this study, Variant Enrichment Analysis (VEA) was developed and applied to identify novel pathways altered in patients with complex autoinflammatory skin disorders.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Allergy

Insights into hidradenitis suppurativa

Kelsey R. van Straalen et al.

Summary: Hidradenitis suppurativa is a chronic, inflammatory skin disorder that affects around 1% of the population and significantly impacts patients' quality of life. It is characterized by inflammatory lesions such as nodules, abscesses, and sinus tracts in areas like the armpits, groin, and buttocks, typically appearing during or after puberty. The development and maintenance of the disease involve a complex interplay of genetic predisposition, hormonal factors, obesity, and smoking. It is believed to stem from a defect in the hair follicle, leading to follicular plugging, cyst formation, and subsequent acute inflammation. Over time, acute lesions progress to a chronic condition with draining sinus tracts and extensive fibrosis. Hidradenitis suppurativa is associated with other immune-mediated inflammatory diseases, metabolic and cardiovascular disorders, and psychiatric comorbidities.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Dermatology

Transcriptome Analysis Reveals Intrinsic Proinflammatory Signaling in Healthy African American Skin

Anna Klopot et al.

Summary: Differences in gene expression between darkly pigmented and lightly pigmented skin were found, suggesting the existence of intrinsic proinflammatory circuits in darkly pigmented skin that may contribute to disease disparities. These findings provide a foundation for the development of targeted strategies for skin disease prevention.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Dermatology

Evidence of gene-gene interaction in hidradenitis suppurativa: a nationwide registry study of Danish twins

R. Kjaersgaard Andersen et al.

Summary: The study analyzed data from the Danish Twin Registry and the Danish National Patient Registry to estimate the relative importance of genetic and environmental factors underlying susceptibility to Hidradenitis suppurativa (HS). Results showed that genetics account for the majority of HS susceptibility, with the possibility of up to six interacting loci, indicating gene-gene interactions play a significant role in the disease. The findings suggest new approaches for future HS genome-wide association studies to assess potential interactions at a single-nucleotide polymorphism (SNP)-SNP level.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Article Dermatology

Large-scale serum analysis identifies unique systemic biomarkers in psoriasis and hidradenitis suppurativa

K. Navrazhina et al.

Summary: Hidradenitis suppurativa (HS) and psoriasis share significant similarities in Th1/Th17 enrichment and upregulation of atherosclerosis-related proteins, with HS patients exhibiting a greater serum inflammatory burden despite psoriasis involving a larger body surface area.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Article Dermatology

Assessment of inter-rater reliability of clinical hidradenitis suppurativa outcome measures using ultrasonography

A. B. Lyons et al.

Summary: The study evaluated inter-rater reliability in assessing Hidradenitis suppurativa (HS) disease severity using clinical and ultrasound techniques. It found that ultrasound improved inter-rater agreement among physicians for assessing disease severity, and should be used in conjunction with physical examination findings.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2022)

Article Allergy

High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression

Kristina Navrazhina et al.

Summary: This study characterized lesional, perilesional, and nonlesional skin in patients with HS. It found that perilesional HS skin has a molecular profile comparable to that of lesional skin. HS can be classified into two distinct subtypes based on molecular levels of LCN2 in the skin, with the LCN2-high subtype exhibiting higher overall inflammation and upregulation of targetable cytokines.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Dermatology

Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study

A. V. Marzano et al.

Summary: This study highlights the importance of early use of adalimumab in the treatment of HS, with a significant correlation between therapeutic delay and lack of clinical response at week 16. The efficacy and safety of adalimumab were confirmed, along with improvements in patients' quality of life. Previous use of immunosuppressants could negatively impact response to adalimumab.

BRITISH JOURNAL OF DERMATOLOGY (2021)

Review Dermatology

Race and Ethnicity Gaps in Global Hidradenitis Suppurativa Clinical Trials

Kyla N. Price et al.

Summary: Recent analysis of randomized controlled trials (RCTs) for Hidradenitis Suppurativa (HS) found that the majority of participants were Caucasian and of African descent, while Hispanic, Asian, American Indian, and Native Hawaiian participants were underrepresented. No trials included sub-analysis of treatment efficacy based on race or ethnicity.

DERMATOLOGY (2021)

Article Dermatology

A Systematic Review of Promising Therapeutic Targets in Hidradenitis Suppurativa: A Critical Evaluation of Mechanistic and Clinical Relevance

John W. Frew et al.

Summary: This systematic review evaluates the mechanistic and clinical evidence of new promising therapeutic targets in hidradenitis suppurativa (HS), highlighting the gaps in knowledge and suggesting the need for more comprehensive inflammatory endotype profiling.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)

Article Dermatology

Full exome sequencing of 11 families with Hidradenitis suppurativa

P. Theut Riis et al.

Summary: The study identified mutations in the Notch pathway for all families, as well as mutations in the PSENEN and APH1B of the gamma-secretase genes. Additionally, 161 variants of unknown significance that segregated with the disease within these families were reported. The study concluded that HS is rarely caused by single-gene mutations, suggesting future genetic studies focus on genome-wide association with thousands of cases for suspected polygenic diseases.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Article Allergy

Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa

Kristina Navrazhina et al.

Summary: The study found that tunnels in hidradenitis suppurativa (HS) play an immunologically active role in disease activity, showing inflammation characteristics and associated with increased infiltration of T cells, dendritic cells, and neutrophils. Treatment with medication reduced the size and draining of tunnels, indicating their involvement in disease inflammation.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Dermatology

Investigation of gamma secretase gene complex mutations in German population with Hidradenitis suppurativa designate a complex polygenic heritage

S. Vural et al.

Summary: Hidradenitis suppurativa (HS) is a chronic inflammatory disease affecting apocrine gland-bearing skin, with some cases showing mutations in the gamma secretase gene complex. The genetic basis of HS was investigated in this study by sequencing genes encoding the gamma secretase complex and performing genetic mapping with parametric linkage analysis. Results suggest rare mutations in the gamma secretase gene complex in HS patients, and a possible complex multi-genic inheritance in a multi-generational HS family.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Review Dermatology

Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary

John W. Frew et al.

Summary: In order to establish and validate consensus definitions for typical morphological findings for hidradenitis suppurativa (HS) lesions, this study used the Delphi study technique and achieved agreement among international experts, supporting the importance of standardized terminology for lesion identification in clinical trials.

JAMA DERMATOLOGY (2021)

Article Dermatology

Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa

Y. Cao et al.

Summary: This study identified potential predictive biomarkers, including HCC-4, calprotectin, and fractalkine, for adalimumab response in patients with hidradenitis suppurativa (HS), as well as possible tumor necrosis factor-independent disease pathways. Additionally, it found that certain cytokines involved in inflammatory responses may contribute to disease drivers in adalimumab nonresponders.

BRITISH JOURNAL OF DERMATOLOGY (2021)

Review Dermatology

Insights from γ-Secretase: Functional Genetics of Hidradenitis Suppurativa

Gautham Vellaichamy et al.

Summary: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with significant heritability and racial predisposition. The pathogenesis of HS is complex, with some patients associated with mutations in gamma-secretase, which may be a pathway underlying HS.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)

Editorial Material Dermatology

Unraveling the Heterogeneity of Hidradenitis Suppurativa with Schema

Joslyn S. Kirby

Summary: Facing the challenge of hidradenitis suppurativa, understanding the variability in disease manifestations and treatment responses is crucial. Research suggests that formulating HS phenotypes can help guide treatment and predict outcomes. Future studies should focus on evaluating the reliability of the research and predictive validity.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)

Article Dermatology

Comparing the Effectiveness and Safety Associated With Infliximab vs Infliximab-abda Therapy for Patients With Hidradenitis Suppurativa

Linnea Lackstrom Westerkam et al.

Summary: This study aimed to compare the effectiveness of infliximab and infliximab-abda in the treatment of hidradenitis suppurativa. The results showed that both treatments were associated with similar and significant improvements in disease.

JAMA DERMATOLOGY (2021)

Article Dermatology

Anti-COVID-19 measurements for hidradenitis suppurativa patients

Nisha Suyien Chandran et al.

Summary: The reported incidence of COVID-19 among patients with inflammatory bowel and skin diseases under treatment with biologicals is low. Treatment may modify disease severity, but the vaccination and management of biological treatments in patients with hidradenitis suppurativa (HS) may not negatively impact susceptibility to COVID-19.

EXPERIMENTAL DERMATOLOGY (2021)

Review Dermatology

Hidradenitis suppurativa in East and Southeast Asian populations: a systematic review and meta-analysis

Ryan Daniel Gotesman et al.

Summary: This study conducted the first systematic review and meta-analysis on HS patients from East and Southeast Asia, finding that most patients were male, about half developed lesions in the axilla and buttocks, and a small subset had positive family history of HS.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2021)

Article Dermatology

Improvement in Hidradenitis Suppurativa and quality of life in patients treated with adalimumab: Real-world results from the HARMONY Study

A. Hafner et al.

Summary: Treatment with adalimumab in patients with moderate-to-severe hidradenitis suppurativa resulted in significant improvements in disease severity, quality of life, and work productivity, with a rapid and sustained response over 52 weeks. No unexpected safety signals were reported.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Letter Dermatology

Assessing the responsiveness of sonographic biomarkers to Brodalumab therapy in Hidradenitis Suppurativa

J. W. Frew et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Article Dermatology

Real-world effectiveness of adalimumab in patients with moderate-to-severe hidradenitis suppurativa: the 1-year SOLACE study

W. Gulliver et al.

Summary: The study found that patients with moderate and high AN counts achieved better results at 24 and 52 weeks of treatment with adalimumab, with gender and age at onset affecting treatment effectiveness. The use of adalimumab led to a decrease in lesions, especially in inflammatory nodules, and the IHS4 scores of responders were substantially lowered. No new safety issues were detected during the treatment and observation period.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Review Dermatology

Race-Specific Prevalence of Hidradenitis Suppurativa

Muskaan Sachdeva et al.

Summary: This study investigated the race-specific prevalence of Hidradenitis suppurativa (HS) and found the highest rates among African American populations, lowest among Hispanics/Latinos, and intermediate among Caucasian populations. Other ethnic groups had minor prevalence compared to African American and Caucasian populations. Further international research is needed to accurately assess the frequency and underlying etiology of HS among varying racial populations.

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2021)

Article Medicine, Research & Experimental

Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-α therapy

Margaret M. Lowe et al.

JCI INSIGHT (2020)

Editorial Material Dermatology

A Call to Accelerate Hidradenitis Suppurativa Research and Improve Care-Moving Beyond Burden

Haley B. Naik et al.

JAMA DERMATOLOGY (2019)

Article Multidisciplinary Sciences

Specimen Collection for Translational Studies in Hidradenitis Suppurativa

A. S. Byrd et al.

SCIENTIFIC REPORTS (2019)

Article Dermatology

Incidence of hidradenitis suppurativa in the United States: A sex- and age-adjusted population analysis

Amit Garg et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

Article Medicine, General & Internal

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa

Alexa B. Kimball et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Multidisciplinary Sciences

γ-Secretase Gene Mutations in Familial Acne Inversa

Baoxi Wang et al.

SCIENCE (2010)